SYMTUZA 200 MG
EMTRICITABINE : 200 MG TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) : 10 MG COBICISTAT : 150 MG DARUNAVIR (DARUNAVIR ETHANOLATE) : 800 MG · DIN 02473720 · JANSSEN INC
Health Canada status: MARKETED
What is SYMTUZA?
SYMTUZA 200 MG contains EMTRICITABINE : 200 MG TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) : 10 MG COBICISTAT : 150 MG DARUNAVIR (DARUNAVIR ETHANOLATE) : 800 MG. It is listed in the Health Canada Drug Product Database under DIN 02473720, held by JANSSEN INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 25-Apr-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SYMTUZA used for?
SYMTUZA ® (darunavir/cobicistat/emtricitabine/tenofovir alafenamide) is indicated as a complete regimen for: • the treatment of human immunodeficiency virus type 1 (HIV - 1) infection in adults and adolescents (aged 12 years and older with body weight at least 40 kg) and with no known mutations associated with resistance to the individual components of SYMTUZA ® .
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02473720 |
|---|---|
| Brand name | SYMTUZA |
| Generic / active ingredient | EMTRICITABINE : 200 MG TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) : 10 MG COBICISTAT : 150 MG DARUNAVIR (DARUNAVIR ETHANOLATE) : 800 MG |
| Manufacturer | JANSSEN INC |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J05AR22 EMTRICITABINE, TENOFOVIR ALAFENAMIDE, DARUNAVIR AND COBICISTAT |
| AHFS class | 08:18.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 25-Apr-2018 |
| Original market date | 2018-04-25 00:00:00 |
How is it stored and handled?
null
How is it supplied?
Each bottle contains 30 tablets.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.